Therapy Areas
17 June 2024 - Immunotherapy company Northwest Biotherapeutics (OTCQB: NWBO) announced on Monday that it has secured an exclusive license from Roswell Park Comprehensive Cancer Center for a portfolio of dendritic cell technologies and intellectual pr...
17 June 2024 - Alternative asset management firm TPG (NASDAQ: TPG) declared on Monday that it has made a strategic investment in K2 Medical Research, an integrated clinical trial site platform specialising in central nervous system trials.Founded by ...
17 June 2024 - Eye health company Bausch + Lomb Corporation (NYSE: BLCO) (TSX: BLCO) announced on Wednesday that it will present new scientific data and host educational events at the European Dry Eye Society (EuDEC) 2024 Congress in Madrid, Spain, f...
17 June 2024 - Immunotherapy company Innate Pharma SA (Euronext Paris: IPH) (Nasdaq: IPHA) on Monday announced updated results from the Phase 1/2 trial of SAR443579/IPH6101 (SAR'579), a first-in-class NK cell engager targeting CD123.Developed un...
17 June 2024 - Immuno-oncology company AstraZeneca (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Monday that Imfinzi (durvalumab), combined with carboplatin and paclitaxel followed by Imfinzi monotherapy, has received US FDA approval for treating ...
17 June 2024 - Cell-free DNA and genetic testing company Natera Inc (NASDAQ: NTRA) announced on Monday that it has introduced the Prospera Heart test with Donor Quantity Score (DQS), improving the detection of rejection in heart transplant patients. ...
17 June 2024 - Takeda (TSE:4502/NYSE:TAK), a Japanese multinational pharmaceutical company, announced on Friday the signing of an option agreement with China-based Ascentage Pharma to enter into an exclusive license agreement for olverembatinib, an o...